Search by Drug Name or NDC

    NDC 00363-0227-14 Aspirin 325 mg/1 Details

    Aspirin 325 mg/1

    Aspirin is a ORAL TABLET, DELAYED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreen Company. The primary component is ASPIRIN.

    Product Information

    NDC 00363-0227
    Product ID 0363-0227_53192e17-ac0f-4665-ba66-e167de02634e
    Associated GPIs 64100010000605
    GCN Sequence Number 004381
    GCN Sequence Number Description aspirin TABLET DR 325 MG ORAL
    HIC3 H3D
    HIC3 Description ANALGESIC/ANTIPYRETICS, SALICYLATES
    GCN 16720
    HICL Sequence Number 001820
    HICL Sequence Number Description ASPIRIN
    Brand/Generic Generic
    Proprietary Name Aspirin
    Proprietary Name Suffix Enteric Coated, Regular Strength
    Non-Proprietary Name Aspirin
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 325
    Active Ingredient Units mg/1
    Substance Name ASPIRIN
    Labeler Name Walgreen Company
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M013
    Listing Certified Through 2024-12-31

    Package

    NDC 00363-0227-14 (00363022714)

    NDC Package Code 0363-0227-14
    Billing NDC 00363022714
    Package 500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0363-0227-14)
    Marketing Start Date 1992-12-14
    NDC Exclude Flag N
    Pricing Information N/A